Results 81 to 90 of about 37,349 (258)

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Mapping heterogeneity in the management of malignant pleural effusions with indwelling pleural catheters in Denmark - a national survey

open access: yesEuropean Clinical Respiratory Journal
Background Malignant pleural effusion (MPE) affects up to 20% of cancer patients, causing dyspnea and frequent hospitalizations. Treatment includes thoracentesis, pleurodesis, and indwelling pleural catheters (IPC).
Aras K. M. Ali   +5 more
doaj   +1 more source

From Awareness to Action: Consumer Behaviour, Attitudes and Business Strategy in Sustainable and Circular Electronic Devices

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Technological change and the increasing use of electronic devices have made electronic waste one of the fastest‐growing waste streams worldwide, posing significant environmental and social challenges. Thus, understanding consumer behaviour regarding the purchase, use and disposal of electronic products is key to developing effective circular ...
Idiano D'Adamo   +4 more
wiley   +1 more source

Key factors associated with China’s basic medical insurance fund revenue-expenditure balance: a grey relational analysis

open access: yesCost Effectiveness and Resource Allocation
Introduction The financial equilibrium of China’s Basic Medical Insurance Fund (BMIF) is pivotal, as it directly influences the sustainability, equity, and stability of the healthcare security system.
Guangwen Gong   +3 more
doaj   +1 more source

Should annual cost of the drug inform reimbursement decisions? A perspective from China’s healthcare security system

open access: yesFrontiers in Public Health
BackgroundAn increasing number of countries worldwide, including China, have adopted Health Technology Assessment (HTA) and pharmacoeconomic (PE) principles, either comprehensively or partially, to inform drug reimbursement decisions.
Xiaochen Peng   +5 more
doaj   +1 more source

The impact of diagnosis subject to reimbursement on life expectancy, the ability to work, and the quality of life: The experts’ assessment

open access: yesSHS Web of Conferences, 2014
The ex-post retrospective analysis of the health care reform in Latvia has been performed by several authors; therefore in writing this paper, the author also considered it essential to try and predict its future prospects, specifically, to carry out an ...
Araja D.
doaj   +1 more source

Orchestrating Circularity in UK Accident Repair: An Intermediary Perspective on Green Parts and Reverse Logistics

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This study examines the drivers and barriers shaping the adoption of salvaged automotive components (‘green parts’) in the UK accident repair sector and evaluates the strategic implications for intermediary firms in fragmented service ecosystems.
Gu Pang   +3 more
wiley   +1 more source

How Do Global Fashion Supply Chains Respond to Structural Pressures? Examining Sustainability Conduct Through a Spatial–Temporal–Functional Lens

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT The fashion industry is facing unprecedented structural pressures, including increasing regulatory demands and rising expectations for social accountability. This study examines how global fashion supply chains respond to such pressures to advance sustainability.
Diletta Tosetto   +2 more
wiley   +1 more source

Status and future of recombinant adeno‐associated virus vector manufacturing

open access: yesBiotechnology Progress, EarlyView.
Abstract Sixty years of adeno‐associated virus (AAV) research illustrates a trajectory marked by basic science exploration, iterative innovation, persistent challenges, a number of clinical setbacks, as well as commercial therapeutic triumphs. This continual evolution has led to recombinant AAV (rAAV) becoming a cornerstone of modern gene therapy ...
Frank Agbogbo, David Dismuke
wiley   +1 more source

Home - About - Disclaimer - Privacy